Monthly News Roundup – September 2020
Genentech’s Gavreto Cleared for RET Fusion-Positive NSCLC Gavreto (pralsetinib) is a RET kinase inhibitor used for the treatment of adults
Read more
September shines golden spotlight on childhood cancer
A lot can happen in a year: more than 950 children aged under 18 will be diagnosed with cancer and
Read more